The induction of SENP3 in cancer cells initiates the angiogenic pathway; specifically SENP3 regulates the transcriptional activity of hypoxia-inducible factor 1α (HIF1α) via desumoylation of the co-regulatory protein p300. Here, EP300 is linked to cancer.